Scholarlink

Risvan® is a long-acting injectable (LAI) antipsychotic, which provides immediate and sustained plasma levels. It does not require loading doses or supplementation with oral risperidone. This medication is not available in the United States currently, and information from the company states that there are no plans to market the medication. This chapter provides clinical pearls on how to appropriately prescribe and administer Risvan®.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Risperidone for Extended-Release Injectable Suspension (Risvan®): Second-Generation Antipsychotic Long-Acting Injectable

  • 章节

  • 发表日期：

    2025年

查看全文
  • Megan J. Ehret

摘要

Risvan® is a long-acting injectable (LAI) antipsychotic, which provides immediate and sustained plasma levels. It does not require loading doses or supplementation with oral risperidone. This medication is not available in the United States currently, and information from the company states that there are no plans to market the medication. This chapter provides clinical pearls on how to appropriately prescribe and administer Risvan®.